SEC Form D private-offering filing

Tempero Bio, Inc.

Name: Tempero Bio, Inc. - new SEC Form D private-offering filing, Oakland, CA
Published: 2025-11-04

A new SEC Form D private-offering notice from Oakland, CA, a $76,958,457 filer-stated offering target in Biotech. The source filing is one click away.

Tempero Bio, Inc. site↗ Verified via SEC Form D

Clinical-stage biopharmaceutical company developing TMP-301, an oral therapy for substance use disorders including alcohol and cocaine use disorder

Filed 2025-11-04Filed to raise $76,958,457First money in 2024-10-30Raised so far $76,958,457HQ (as filed) Oakland, CASector Biotech ✓Stage (inferred) GrowthCall status Late filing

Source linked the Form D on EDGAR↗Website verified temperobio.com↗Named in the filing 7 executives & directors

Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.